Hyperprolinemia type 2

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:79101OMIM:239510E72.5
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hyperprolinemia type 2 (also called HPI2 or delta-1-pyrroline-5-carboxylate dehydrogenase deficiency) is a rare inherited metabolic disorder. It happens when the body cannot properly break down an amino acid called proline. Amino acids are the building blocks of protein. In this condition, a specific enzyme called pyrroline-5-carboxylate dehydrogenase (P5CDh) does not work correctly, causing proline and a related compound called pyrroline-5-carboxylate (P5C) to build up in the blood and urine. Many people with hyperprolinemia type 2 have no symptoms at all and are discovered only through routine newborn screening or family testing. However, some individuals — especially children — may experience seizures or other neurological problems. The buildup of P5C is thought to interfere with vitamin B6 (pyridoxine) in the brain, which may explain why some patients have seizures that respond to vitamin B6 supplementation. Treatment is mainly focused on managing symptoms. There is no cure, but a low-protein or proline-restricted diet and vitamin B6 supplementation are the main approaches used. The overall outlook for most people with this condition is good, especially when it is identified early and managed carefully. Regular follow-up with a metabolic specialist is important.

Also known as:

Key symptoms:

Seizures or epilepsyIntellectual disability or learning difficultiesElevated proline levels in the blood (hyperprolinemia)Elevated proline in the urineBehavioral or developmental problemsVitamin B6-responsive seizuresNo symptoms at all in some people (asymptomatic)

Clinical phenotype terms (50)— hover any for plain English
Abnormal cerebrospinal fluid morphologyHP:0002921HydroxyprolinuriaHP:0003080ProlinuriaHP:0003137HyperprolinemiaHP:0008358Increased urine alpha-ketoglutarate concentrationHP:0012402HyperglycinemiaHP:0002154HyperalaninemiaHP:0003348Reduced circulating vitamin B6 circulatingHP:0008326
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hyperprolinemia type 2.

View clinical trials →

No actively recruiting trials found for Hyperprolinemia type 2 at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hyperprolinemia type 2 community →

No specialists are currently listed for Hyperprolinemia type 2.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hyperprolinemia type 2.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hyperprolinemia type 2Forum →

No community posts yet. Be the first to share your experience with Hyperprolinemia type 2.

Start the conversation →

Latest news about Hyperprolinemia type 2

No recent news articles for Hyperprolinemia type 2.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Does my child (or I) need to follow a low-proline diet, and how strict does it need to be?,Should we try vitamin B6 supplementation, and what dose is safe?,How often should proline levels be checked in the blood and urine?,Are other family members at risk, and should they be tested?,What signs should prompt me to go to the emergency room?,Are there any clinical trials or research studies we could join?,What kind of school or developmental support might my child need?

Common questions about Hyperprolinemia type 2

What is Hyperprolinemia type 2?

Hyperprolinemia type 2 (also called HPI2 or delta-1-pyrroline-5-carboxylate dehydrogenase deficiency) is a rare inherited metabolic disorder. It happens when the body cannot properly break down an amino acid called proline. Amino acids are the building blocks of protein. In this condition, a specific enzyme called pyrroline-5-carboxylate dehydrogenase (P5CDh) does not work correctly, causing proline and a related compound called pyrroline-5-carboxylate (P5C) to build up in the blood and urine. Many people with hyperprolinemia type 2 have no symptoms at all and are discovered only through rout

How is Hyperprolinemia type 2 inherited?

Hyperprolinemia type 2 follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.